Elección del ligando en biología estructural: sustratos de proteínas o inhibidores conocidos

Value of the Information & Strength of the Argument

The value of the information is high for researchers and students in structural biology and computational chemistry. The presenter provides a comprehensive overview of ligand selection criteria, backed by practical examples and references to established tools like AutoDock and GROMACS. The argumentation is solid, as it systematically explains the rationale behind each step, from initial ligand choice to validation metrics. However, the talk is largely based on expert opinion and internal seminar experience rather than original research, which limits its novelty. The discussion of specific case studies, such as the COVID-19 Mpro inhibitor study, adds credibility and illustrates the application of the concepts. The presenter also addresses common pitfalls, such as atomic clashes and the need for robust clustering, which enhances the practical value.

Scientific Rigor, Source Quality, Title Accuracy

The scientific rigor is moderate. The presenter references established concepts and tools but does not provide formal citations or links to specific papers. The quality of sources is inferred from the context, such as mentioning the PDB and specific software. The title accurately reflects the content, focusing on ligand selection in structural biology. The seminar is an internal presentation, so it lacks the rigor of a peer-reviewed publication. However, the presenter demonstrates a good understanding of the subject and provides practical insights that are valuable for practitioners. The adequacy between title and content is strong, as the talk directly addresses the topic of ligand selection with examples from protein substrates and inhibitors.

The title accurately reflects the content, which focuses on ligand selection in structural biology, including protein substrates and known inhibitors.

7/10

The content is an internal seminar by a researcher, providing practical insights and examples from structural biology and molecular docking. It is based on established knowledge and includes references to specific tools and metrics, but lacks formal citations and peer-reviewed sources.

Markers derived by PSI from the transcript: the creator did not define chapters.

• 00:00Introduction to the seminar and the MMS protein family, emphasizing their dynamic nature and role in DNA repair.
• 02:00Explanation of molecular docking scenarios: protein-ligand, protein-DNA, and protein-protein interactions.
• 05:00Discussion on the objective of ligand selection: determining binding free energy and the importance of negative values for spontaneous processes.
• 08:00Criteria for ligand selection: electrostatic complementarity, entropy, and conformational states.
• 12:00Use of ATP/ADP as ligands and the role of divalent cations in stabilizing the active site.
• 15:00Discussion on conformational states and the selection of ligands based on open/closed conformations.
• 18:00Introduction to substrate mimicry and non-hydrolyzable analogs like AMPPNP for capturing transition states.
• 21:00Physicochemical criteria for ligand selection: charge complementarity, hydration optimization, and hydrogen bonding.
• 24:00DNA as a ligand: selection of oligonucleotide substrates and the importance of pre-bent DNA for recognition complexes.
• 27:00Protein-protein docking: selecting interaction interfaces based on evolutionary conservation and peptide mimics.
• 30:00Validation metrics: binding energy, RMSD, interaction analysis, and clustering. Distinction between validation and discovery docking.
• 33:00Case study on COVID-19 Mpro inhibitors, including redocking validation and molecular dynamics simulations.

• WhatsApp Channel of IGBM — Mentioned in the description as a way to join the institute's channel for free talks and updates.

• Molecular docking — General reference for molecular docking concepts and methods.
• DNA mismatch repair — Background on the MMS protein family and their role in DNA repair.